ACD PHARMACEUTICALS AS: årsregnskap 2004 vs 2003
Grew 31% on revenue, weaker earnings
Summary
What changed
Comparing Årsregnskap 2004 with 2003 for ACD PHARMACEUTICALS AS. Revenue 1.26m NOK → 1.65m NOK (+30.6%). Net result +11.46m NOK → +484.1k NOK. Equity 355.3k NOK → 364.7k NOK.
On the constructive side: revenue rose; operating result improved; equity strengthened. Pressures included: net result weakened.
Also worth watching: payroll increased; cogs moved. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 1.26m NOK to 1.65m NOK (+30.6% YoY). Calculated
-
↑
Operating result improved
Operating result +598.0k NOK → +639.9k NOK (op. margin 47.5% → 38.9%). Calculated
-
↑
Equity strengthened
Book equity 355.3k NOK → 364.7k NOK. Calculated
What deteriorated
-
↓
Net result weakened
Net result +11.46m NOK → +484.1k NOK (net margin 909.2% → 29.4%). Calculated
Things to notice
-
·
Payroll increased
Salary cost 4 NOK → 3.14m NOK (0% → 191% of revenue). Calculated
-
·
COGS moved
COGS / varekostnad 1 NOK → 280.5k NOK (+28051900.0% YoY). Calculated